HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
- Status
- TERMINATED
- Phase
- PHASE2
Administration of Donor T Cells With the Caspase-9 Suicide Gene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)
- Status
- COMPLETED
- Phase
- PHASE2
PRO#0118: Decitabine Plus Mini Flu-Bu
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE1
Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation
- Status
- TERMINATED
- Phase
- PHASE3
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
- Status
- COMPLETED
- Phase
- N/A
Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry
- Status
- COMPLETED
- Phase
- N/A
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)
- Status
- UNKNOWN
- Phase
- PHASE4